CLEARCOLL PTY LTD has a total of 12 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and organic fine chemistry are GALDERMA SA, LITHERA INC and PREC DERMATOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | Canada | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Macromolecular compounds compositions | |
#4 | Specific use of cosmetics | |
#5 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Vidal Linus | 4 |
#2 | Vidal Benedicto De Campos | 4 |
#3 | Cowden William Butler | 2 |
Publication | Filing date | Title |
---|---|---|
AU2003901834A0 | Cross-linked polysaccharide compositions | |
CA2476383A1 | Carbohydrate-based anti-wrinkle and tissue remodelling compounds | |
AUPQ937300A0 | Glycosaminoglycans or their derivatives crosslinked by electromagnetic radiation as dermal fillers | |
AUPQ937400A0 | The use of particles of crosslinked collagen as a dermal or subdermal filler | |
AUPQ937500A0 | The use of crosslinked collagen as a dermal filler to treat superficial wrinkles and scars | |
AUPQ747400A0 | Method for the production of terminally strile injectable collagen | |
AUPQ747300A0 | Method for intradermal crosslinking of dermal fillers | |
AU6713198A | Improved process for the manufacture of collagen |